Article Details

Augmenta Bioworks and TFF Pharmaceuticals Announce Positive In Vitro Data Demonstrating ...

Retrieved on: 2021-07-29 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Augmenta Bioworks and TFF Pharmaceuticals Announce Positive In Vitro Data Demonstrating .... View article details on hiswai:

Excerpt

... that their lead anti-COVID-19 monoclonal antibody (“mAb”) therapy, AUG-3387, binds to and neutralizes the SARS-CoV-2 Delta variant (B.1.617.2).

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up